Treatment With Second-generation Bruton's Tyrosine Kinase Inhibitors (Acalabrutinib, Zanubrutinib)
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Innovative Biomarkers of Cardiovascular Complications Associated With Second-generation Bruton Tyrosine Kinase Inhibitor Treatments: a Single-center Cohort Study (NCT07174141) | Centre Hospitalier Universitaire Dijon | 2025-11-28 |
Track Treatment With Second-generation Bruton's Tyrosine Kinase Inhibitors (Acalabrutinib, Zanubrutinib) automatically
Every clearance here is in the API, with alerts when new ones post.